Yoshiaki Furukawa
Movement Disorders Research Laboratory
Centre for Addiction and Mental Health
The Clarke Division
Toronto
Canada
Name/email consistency: high
- Amantadine for levodopa-induced choreic dyskinesia in compound heterozygotes for GCH1 mutations. Furukawa, Y., Filiano, J.J., Kish, S.J. Mov. Disord. (2004)
- Serum prolactin in symptomatic and asymptomatic dopa-responsive dystonia due to a GCH1 mutation. Furukawa, Y., Guttman, M., Wong, H., Farrell, S.A., Furtado, S., Kish, S.J. Neurology (2003)
- Brain proteasomal function in sporadic Parkinson's disease and related disorders. Furukawa, Y., Vigouroux, S., Wong, H., Guttman, M., Rajput, A.H., Ang, L., Briand, M., Kish, S.J., Briand, Y. Ann. Neurol. (2002)
- Brain biopterin and tyrosine hydroxylase in asymptomatic dopa-responsive dystonia. Furukawa, Y., Kapatos, G., Haycock, J.W., Worsley, J., Wong, H., Kish, S.J., Nygaard, T.G. Ann. Neurol. (2002)
- Dopa-responsive dystonia simulating spastic paraplegia due to tyrosine hydroxylase (TH) gene mutations. Furukawa, Y., Graf, W.D., Wong, H., Shimadzu, M., Kish, S.J. Neurology (2001)
- Striatal dopamine in early-onset primary torsion dystonia with the DYT1 mutation. Furukawa, Y., Hornykiewicz, O., Fahn, S., Kish, S.J. Neurology (2000)
- Scoliosis in a dopa-responsive dystonia family with a mutation of the GTP cyclohydrolase I gene. Furukawa, Y., Kish, S.J., Lang, A.E. Neurology (2000)